abrdn Life Sciences Investors (HQL) ລາຄາ ແລະ ຂ່າວ

ໜ້າທຳອິດHQL • NYSE

abrdn Life Sciences Investors

$12,80

ຫຼັງປິດຕະຫຼາດ:

$12,80

(0,00%)0,00

ປິດແລ້ວ: 9 ມິ.ຖ., 16 ໂມງ 3 ນາທີ 59 ວິນາທີ GMT-4 · USD · NYSE · ຂໍ້ຈຳກັດຄວາມຮັບຜິດຊອບ

abrdn Healthcare Investors

$15,69

HQH0,00%

abrdn Healthcare Opportunities Fund

$18,47

THQ0,00%

abrdn World Healthcare Fund

$10,55

THW0,00%

Abrdn Global Infrastructure Income Fund

$19,69

ASGI0,30%

BlackRock Science and Technolgy Trm Trst

$19,64

BSTZ0,10%

BlackRock ESG Capital Allocatin Trm Trst

$16,10

ECAT0,25%

BlackRock Capital Allocation Term Trust

$15,19

BCAT0,13%

Nuveen Multi-Asset Income Fund

$12,57

NMAI0,079%

Abrdn Total Dynamic Dividend Fund

$8,62

AOD0,23%

BlackRock Health Sciences Term Trust

$14,63

BMEZ1,15%

ຫຼັກຊັບທີ່ມີລາຍຊື່ໃນ ສະຫະລັດສໍານັກງານໃຫຍ່ຕັ້ງຢູ່ ສະຫະລັດ

ປິດກ່ອນໜ້າ

$12,81

ຂອບເຂດລາຄາໃນມື້

$12,75 - $12,91

ຂອບເຂດລາຄາໃນປີ

$10,55 - $15,90

ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ

369,57 ລ້ານ USD

ປະລິມານສະເລ່ຍ

112,87 ພັນ

ຕະຫຼາດຂັ້ນຕົ້ນ

NYSE

ໃນຂ່າວ

Defense World

21 ຊົ່ວໂມງກ່ອນ

Parallel Advisors LLC Has $61,000 Stock Holdings in Abrdn Life Sciences Investors (NYSE:HQL)

Quantisnow

11 ຊົ່ວໂມງກ່ອນ

SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest

ກ່ຽວກັບ

ສ້າງຕັ້ງ

1992

ສໍານັກງານໃຫຍ່

ບອສຕັນ, ມາຊາຊູເຊັດ
ສະຫະລັດ

ເວັບໄຊ

abrdnhql.com